Thought Leadership | Fish & Richardson

Diversity, Equity & Inclusion

Pro Bono & Social Responsibility

Legal Operations

Legal Project Management

Knowledge Management

Legal Technology Services

Patent Litigation

Trademark, Copyright & Media Litigation

Trade Secret Litigation

Standard Essential Patents

Chancery & Corporate Governance

<p><em>Inter Partes </em>Review</p>

Post-Grant Review

<p><em>Ex Parte</em> Reexamination</p>

Supplemental Examination

Patent Prosecution

Strategic Patent Counseling & Opinions

Patent Portfolio Management

Unitary Patent & Unified Patent Court

IP Licensing, Transactions & Agreements

Trademark & Copyright Counseling & Prosecution

Strategic Counseling, Registration & Opinions

Advertising & Marketing

Domain Names & Internet

TTAB Oppositions & Cancellations

Digital Millennium Copyright Act

Transactions & Agreements

Regulatory & Government Affairs

Communications & Spectrum Regulation

Drug & Medical Device Regulation

mHealth & Telemedicine

Privacy & Data Security

Electrical & Computer Technology

Software & Internet

Consumer Electronics

Artificial Intelligence

Digital Media & E-Commerce

Financial, Business & FinTech Services

Telecommunications

Energy & Chemicals

Biotech & Diagnostics

Medical Devices

Pharmaceuticals

Academic Research & Medical Centers

Transportation, Aerospace & Defense

Autonomous Vehicles

Thought Leadership

IP Law Essentials

Post-Grant Annual Reports

Search results

Blog | April 28, 2025

Can Clinical Trials Negate Patentability for Pharma Inventions?

Blog | April 24, 2025

Federal Circuit Finds Beer Trademark Application Nothing but "Chicken Scratch"

Blog | April 23, 2025

Munich Appeals Court Reinforces Security-Centric FRAND Framework in SEP Dispute

Blog | April 16, 2025

Key Insights From the UPC’s First SEP Decision

Blog | March 18, 2025

Federal Circuit: PTE for Reissue Patents Should Be Calculated From Original Patent’s Issue Date

Blog | March 12, 2025

Texas Round-Up: February 2025

Blog | March 03, 2025

Recent Decisions and FTC Challenges Dictate Caution When Listing Patents in the Orange Book

Blog | February 28, 2025

USPTO Rescinds 2022 Guidance on Discretionary Denials

Blog | February 25, 2025

ITC Implements Updated Rules of Practice and Procedure

Blog | February 24, 2025

Biologics and Biosimilars Landscape 2024: IP, Policy, and Market Developments

Blog | February 10, 2025

The Most Interesting Appellate Cases of 2024

Blog | January 29, 2025

Texas Round-Up: December 2024